Prescription Gabapentin 300 mg Capsules Recalled for Cross Contamination
Sun Pharmaceutical is recalling 12,876 bottles of Gabapentin 300 mg capsules distributed nationwide due to cross contamination. The recall is voluntary and ongoing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall initiated voluntarily by the firm. No reported illnesses, deaths, or specific health hazards are mentioned in the source. The recall is precautionary due to cross contamination. FDA Class III recalls are typically scored 1 or 2; without specified high-risk pathogens or reported harm, this is classified as Moderate.
Plain-English summary
Sun Pharmaceutical is recalling Gabapentin 300 mg capsules distributed nationwide due to cross contamination. The recall affects 12,876 bottles with lot numbers HAD1458A (exp. 04/2025), HAD2718A (exp. 07/2025), and HAD3432A (exp. 08/2025).
The firm voluntarily initiated this recall on March 4, 2025. The product is manufactured in Halol, India, and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.
Patients taking medication from these lot numbers should contact their healthcare provider. Pharmacists should not dispense from the affected lots and should return affected product to the supplier.
This recall is ongoing. Consumers should check their medication bottles to verify the lot number and expiration date.
The recalled product
- Product
- GABAPENTIN (GABAPENTIN)
- Brand
- GABAPENTIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Oral Capsule
- Hazard
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # a) HAD1458A
- Exp. date 04/2025
- HAD2718A
- Exp. date 07/2025
- b) HAD3432A
- exp. date 08/2025
UPCs (5)
- 0362756204010
- 0362756202016
- 0362756138025
- 0362756137028
- 0362756139022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GABAPENTIN
- HighGabapentin Capsules Nationwide Recall for Failed Impurity Specifications
FDA (Drugs) · 2025-10-29
- ModerateGabapentin Prescription Capsules Recalled for Failed Impurity Specifications
FDA (Drugs) · 2025-10-29
- HighGabapentin capsules recalled due to inadequately sealed blister packaging
FDA (Drugs) · 2025-07-09
- ModeratePrescription Gabapentin Capsules Recalled for Defective Blister Packaging
FDA (Drugs) · 2025-07-09
- ModerateGlenmark Gabapentin 600mg tablets recalled for manufacturing deviations
FDA (Drugs) · 2025-04-16
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27